179 related articles for article (PubMed ID: 36654601)
1. Cardio-oncology Clinical Assessment and Screening in Patients Undergoing High Toxicity Chemotherapy: A Retrospective Cohort Study.
Regino CA; Cardona-Vélez J; Bello Simanca JD; Miranda Arboleda AF; Gamboa Arroyave JG; Jaimes F
Cureus; 2022 Dec; 14(12):e32513. PubMed ID: 36654601
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of patients referred to cardio-oncology clinic].
Liang L; An T; Zhao XM; Huang LY; Tian PC; Guan JY; Zou CH; Zhang J; Zhang YH
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2183-2186. PubMed ID: 37482731
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Patients' Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs.
Piña P; Taveras A; Khan A; Coyle J; Bueno V; Shah N; Cuello L; Collado S; Mauer A; Danciu S; Herrera CJ
Glob Heart; 2022; 17(1):67. PubMed ID: 36199568
[TBL] [Abstract][Full Text] [Related]
5. "Inherited cardiovascular disease mindset" can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening.
Lorca R; Fernández M; Avanzas P; Pascual I; Álvarez-Velasco R; Silva I; Gutiérrez L; Gómez J; Muñiz M; Álvarez C; Esteban E; López-Fernández T
Int J Cardiol; 2024 Apr; 401():131825. PubMed ID: 38309590
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study.
Fiuza M; Magalhães A; Nobre Menezes M; Costa P; Abreu Ribeiro L; Abreu C; Brás R; Vieira J; Duarte AI; Morais P; Silva B; Costa L; Pinto FJ
Rev Port Cardiol; 2022 Dec; 41(12):979-984. PubMed ID: 36153294
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study.
Yaseen IF; Farhan HA
Front Cardiovasc Med; 2022; 9():972455. PubMed ID: 36247485
[TBL] [Abstract][Full Text] [Related]
8. Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculator.
Abiodun A; Shawe-Taylor M; Tyebally S; Bagkeris E; Bajomo O; Artico J; Slater S; Raisi-Estabragh Z; Diamantis N; Manisty C
ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38845140
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology: what you need to know now for clinical practice and echocardiography.
Larsen CM; Mulvagh SL
Echo Res Pract; 2017 Mar; 4(1):R33-R41. PubMed ID: 28254996
[TBL] [Abstract][Full Text] [Related]
10. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic.
Toro C; Felmingham B; Jhadav M; Celermajer DS; La Gerche A; O'Sullivan J; Kumar S; Mateos MK; Fulbright J; Govender D; Collier L; Cheung M; Eisenstat DD; Lange PW; Ayer J; Elliott DA; Conyers R
Cardiooncology; 2023 Dec; 9(1):45. PubMed ID: 38062530
[TBL] [Abstract][Full Text] [Related]
11. Predictability of cardiotoxicity: Experience of a Belgian cardio-oncology clinic.
Jacobs JEJ; Guler I; Duchenne J; Janssens S; Van Aelst LNL
Int J Cardiol; 2022 Sep; 363():119-122. PubMed ID: 35777489
[TBL] [Abstract][Full Text] [Related]
12. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey.
Lenarczyk R; Potpara TS; Haugaa KH; Deharo JC; Hernandez-Madrid A; Del Carmen Exposito Pineda M; Kiliszek M; Dagres N
Europace; 2017 Sep; 19(9):1579-1584. PubMed ID: 28934410
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of patients with newly diagnosed hematological malignancies referred for echocardiography.
Kępski J; Szmit S; Lech-Marańda E
Front Oncol; 2024; 14():1283831. PubMed ID: 38327743
[TBL] [Abstract][Full Text] [Related]
14. Cardio-Oncology Services: rationale, organization, and implementation.
Lancellotti P; Suter TM; López-Fernández T; Galderisi M; Lyon AR; Van der Meer P; Cohen Solal A; Zamorano JL; Jerusalem G; Moonen M; Aboyans V; Bax JJ; Asteggiano R
Eur Heart J; 2019 Jun; 40(22):1756-1763. PubMed ID: 30085070
[TBL] [Abstract][Full Text] [Related]
15. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
Herrmann J; Lenihan D; Armenian S; Barac A; Blaes A; Cardinale D; Carver J; Dent S; Ky B; Lyon AR; López-Fernández T; Fradley MG; Ganatra S; Curigliano G; Mitchell JD; Minotti G; Lang NN; Liu JE; Neilan TG; Nohria A; O'Quinn R; Pusic I; Porter C; Reynolds KL; Ruddy KJ; Thavendiranathan P; Valent P
Eur Heart J; 2022 Jan; 43(4):280-299. PubMed ID: 34904661
[TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology: where do we stand for in Belgium?
Lancellotti P; De Pauw M; Claeys M
Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
[TBL] [Abstract][Full Text] [Related]
17. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
[TBL] [Abstract][Full Text] [Related]
18. The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.
Minasian L; Dimond E; Davis M; Adhikari B; Fagerstrom R; Fabian C; Floyd J; Unger JM; Douglas PS; Mustian KM; Chow EJ; Lipshultz S; Hundley WG; Armenian S; Ky B
JACC CardioOncol; 2019 Sep; 1(1):105-113. PubMed ID: 32529192
[TBL] [Abstract][Full Text] [Related]
19. Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic.
Doukas PG; Patel RN; Venkatesh V; Khan SS; Baldridge A; Akhter N
Breast Cancer Res Treat; 2021 Nov; 190(1):133-142. PubMed ID: 34390418
[TBL] [Abstract][Full Text] [Related]
20. Joining Forces: Establishing a Cardio-oncology Clinic.
Austin-Mattison C
J Adv Pract Oncol; 2018 Mar; 9(2):222-229. PubMed ID: 30588356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
